The earnings call highlighted significant achievements, including strong revenue growth, positive clinical trial results, and successful international expansion with Vibativ, which outweighed the limited challenges such as the net loss and pending FDA inspection for Vaprisol.

Company Guidance -

Q3 2025

During the second quarter of 2025, Cumberland Pharmaceuticals reported a 10% year-over-year increase in revenue, totaling $10.8 million. Year-to-date revenues reached $22.6 million, reflecting a 23% increase over the prior year. The company's adjusted earnings for the quarter were $0.4 million, contributing to $2.8 million or $0.18 per share for the first half of the year. The balance sheet showed $68 million in total assets, with $16 million in cash and cash equivalents, $40 million in liabilities, and $28 million in shareholders' equity. Notably, Cumberland's marketed brands, including Kristalose, Sancuso, Vibativ, and Caldolor, contributed significantly to the financial performance. The company also highlighted positive developments in its clinical pipeline, particularly the promising Phase II results for ifetroban in treating Duchenne muscular dystrophy.

Positive Phase II Study Results for Ifetroban

The Phase II study for ifetroban in patients with Duchenne muscular dystrophy showed a 5.4% improvement in cardiac functions, positioning it as a potential treatment for DMD cardiomyopathy.

Vibativ Approval in China

Vibativ received regulatory approval in China, opening access to the world's second-largest pharmaceutical market.

Strong Revenue Growth

Second-quarter revenue was $10.8 million, a 10% increase over the previous year, and year-to-date revenue was $22.6 million, a 23% increase.

Successful Financial Performance

Year-to-date adjusted earnings were $2.8 million or $0.18 per share, a significant increase from the previous year.

New Partnerships and Market Expansions

Partnership with Tabuk Pharmaceuticals to introduce Vibativ to the Middle East and a supply arrangement with Vizient for Vibativ distribution in the U.S.

Cumberland Pharmaceuticals (CPIX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

CPIX Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 11, 2025	2025 (Q3)	- / -	-0.11	―	―	―
Aug 05, 2025	2025 (Q2)	- / -0.05	-0.077	35.06% (+0.03)	―
May 06, 2025	2025 (Q1)	- / 0.08	-0.138	159.42% (+0.22)	―
Mar 04, 2025	2024 (Q4)	- / -0.14	-0.444	69.37% (+0.31)	―
Nov 07, 2024	2024 (Q3)	- / -0.11	-0.074	-48.65% (-0.04)	―
Aug 06, 2024	2024 (Q2)	- / -0.08	0.06	-228.33% (-0.14)	―
May 07, 2024	2024 (Q1)	- / -0.14	0.013	-1161.54% (-0.15)	―
Mar 05, 2024	2023 (Q4)	- / -0.44	-0.17	-161.18% (-0.27)	―
Nov 07, 2023	2023 (Q3)	- / -0.07	-0.03	-146.67% (-0.04)	―
Aug 08, 2023	2023 (Q2)	- / 0.06	-0.09	166.67% (+0.15)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

CPIX Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 05, 2025	$3.79	$3.21	-15.30%
May 06, 2025	$4.41	$4.42	+0.23%
Mar 04, 2025	$6.05	$6.77	+11.90%
Nov 07, 2024	$1.20	$1.19	-0.83%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Cumberland Pharmaceuticals Inc. (CPIX) report earnings?

Cumberland Pharmaceuticals Inc. (CPIX) is schdueled to report earning on Nov 11, 2025, After Close (Confirmed).

What is Cumberland Pharmaceuticals Inc. (CPIX) earnings time?

Cumberland Pharmaceuticals Inc. (CPIX) earnings time is at Nov 11, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is CPIX EPS forecast?

Currently, no data Available

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing